National Registry of Surgical Treatment and Percutaneous Cryoablation of Parietal Endometriosis
NCT ID: NCT06356831
Last Updated: 2025-11-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
300 participants
OBSERVATIONAL
2024-06-15
2028-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of the Prevalence of Endometriosis and Adenomyosis
NCT06211569
Percutaneous Radiofrequency Ablation of Parietal Endometriosis (PRFA)
NCT04333017
Efficacy of Cryoablation of Abdominal Wall Endometriosis
NCT03627676
ENDOMED: Evaluation of the Evolution of Endometriosis Lesions on Imaging Under Medical Treatment
NCT05722314
Endometriosis of the Recto-sigmoid: MRI (Magnetic Resonance Imaging) Criteria Predictive of Shaving or Segmental Resection
NCT03931603
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Symptomatic parietal endometriosis (VAS \> 3 OR bothersome bleeding OR reported impact on quality of life)
Exclusion Criteria
* Minor patient (\< 18 years)
* Pregnant patient at any trimester
* Patient with hemostasis disorders (constitutional or acquired)
* Patient with systemic infection or localized scar infection upon inclusion.
* Patient with contraindications to MRI
* Female patient with a planned medical or surgical procedure for the duration of the study that may interfere with the proper conduct of the study.
* Patient unable to understand the information provided
* Patient who is not affiliated to the social security system
* Patient under curatorship or tutorship
* Patient with a nodule of primary or secondary malignant tumor origin
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Intercommunal Creteil
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Léo RAZAKAMAMANTSOA
Role: PRINCIPAL_INVESTIGATOR
CHIC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU bordeaux
Bordeau, , France
Clinique Tivoli
Bordeaux, , France
CHU Clermont Ferrand
Clermont-Ferrand, , France
CHI Creteil
Créteil, , France
Lyon Hôpital La Croix Rousse
Lyon, , France
Lyon Hôpital Sud
Lyon, , France
Lyon Louis Pradel
Lyon, , France
APHM-Hôpital Nord
Marseille, , France
APHP-Hôpital la Conception La Timone
Marseille, , France
CHU Montpellier
Montpellier, , France
CHU Nime
Nîmes, , France
AP-HP - Tenon
Paris, , France
AP-HP Hôpital Européen Georges Pompidou
Paris, , France
APHP Cochin-Port Royal
Paris, , France
APHP-La Pitié
Paris, , France
CHU Strasbourg
Strasbourg, , France
CHU Toulouse
Toulouse, , France
CH Valencienne
Valenciennes, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Anthony DOHAN, Pr
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Endomecryo
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.